FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia

Inflammatory Bowel Diseases

Volumn 20, Issue 2, 2014, Pages 271-277

  Papadia, Cinzia ^a,b   Louwagie, Joost ^c   Del Rio, Paolo ^b   Grooteclaes, Madeleine ^c   Coruzzi, Alessandro ^b   Montana, Chiara ^b   Novelli, Marco ^d   Bordi, Cesare ^e   De'Angelis, Gian Luigi ^b   Bassett, Paul ^f   Bigley, Joseph ^c   Warren, Bryan ^g   Atkin, Wendy ^h   Forbes, Alastair ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c MDxHealth   (Belgium)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF PARMA   (Italy)

^f Statsconsultancy Ltd   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Colitis associated colorectal cancer; FOXE1; Hypermethylation; Surveillance; SYNE1; Ulcerative colitis

Indexed keywords

TUMOR MARKER; DNA; FORKHEAD TRANSCRIPTION FACTOR; FOXE1 PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; SYNE1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER TISSUE; COLITIS; COLITIS ASSOCIATED COLORECTAL CANCER; COLON ADENOMA; COLON MUCOSA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA METHYLATION; DYSPLASIA; FEMALE; FOXE1 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOTHESIS; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NDRG4 GENE; PHACTR3 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SYNE1 GENE; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS; ADENOCARCINOMA; BIOSYNTHESIS; COLORECTAL NEOPLASMS; COMPLICATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ADULT; AGED; BIOMARKERS, TUMOR; COLITIS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84893778094     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000435443.07237.ed     Document Type: Article

References (37)

1. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology. 2004;126: 1634-1648.
2. Clevers H. At the crossroads of inflammation and cancer. Cell. 2004;118: 671-674.
3. Ahmadi A, Polyak S, Draganov PV. Colorectal cancer surveillance in inflammatory bowel disease: the search continues. World J Gastroenterol. 2009;15:61-66.
4. Nuako KW, Ahlquist DA, Mahoney DW, et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology. 1998;115:1079-1083.
5. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in IBD. Gastroenterology. 2010;138:738-745.
6. Svartz N, Ernberg T. Cancer coli in cases of colitis ulcerosa. Acta Med Scand. 1949;135:444-447.
7. Rosenqvist H, Ohrling H, Lagercrantz R, et al. Ulcerative colitis and carcinoma coli. Lancet. 1950;1:906-908.
8. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990;336:357-359.
9. Jess T, Winther KV, Munkholm P, et al. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther. 2004;19:287-293.
10. Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724-2729.
11. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35:950-954.
12. Ullman T, Croog V, Harpaz N, et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003;125:1311-1319.
13. Jess T, Loftus EV, Velayos FS, et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population based study from Olmsted County, Minnesota. Inflamm Bowel Dis. 2006;12:669-676.
14. Greenstein AJ, Slater G, Heimann TM, et al. A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg. 1986;203:123-128.
15. Harpaz N, Talbot IC. Colorectal cancer in idiopathic inflammatory bowel disease. Semin Diagn Pathol. 1996;13:339-357.
16. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
17. Eaden J, Abrams K, McKay H, et al. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol. 2001;194:152-157.
18. Melville DM, Jass JR, Morson BC, et al. Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol. 1989;20:1008-1014.
19. Dixon MF, Brown LJ, Gilmour HM, et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology. 1988;13: 385-397.
20. Noffsinger AE, Miller MA, Cusi MV, et al. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis. Cancer. 1996;78:2307-2312.
21. Dundas SA, Kay R, Beck S, et al. Can histopathologists reliably assess dysplasia in chronic inflammatory bowel disease? J Clin Pathol. 1987;40: 1282-1286.
22. Awais D, Siegel CA, Higgins PDR. Modelling dysplasia detection in ulcerative colitis. Clinical implications of surveillance intensity. Gut. 2009;58:1498-1503.
23. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
24. Mathy C, Schneider K, Chen YY, et al. Gross versus macroscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm Bowel Dis. 2003;9:351-355.
25. Lindberg J, Stenling R, Palmqvsit R, et al. Efficiency of colorectal cancer surveillance in patients with ulcerative colitis; 26 years of experience in a patient cohort from a defined population area. Scand J Gastroenterol. 2005;40:1076-1080.
26. Souici AC, Mirkovitch J, Hausel P, et al. Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide-releasing compounds. Carcinogenesis. 2000;21:281-287.
27. Sato F, Harpaz N, Shibata D. Hypermethylation of the p14 (ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res. 2001; 62:1148-1151.
28. Santini V, Kantarjian HM, Issa JP. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med. 2001;134:573-586.
29. Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA. 1999;96:8681-8686.
30. Hussain SP, Amstad P, Raja K, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 2000;60:3333-3337.
31. Issa JP, Ahuja N, Toyota M, et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001;61:3573-3577.
32. Nelson R, Louwagie J. Two newly identified genes (FOXE1 and SYNE1) in colorectal cancer. Clin Oncol News. 2009;12:72-73.
33. Dhir M, Yachida S, Van Neste L, et al. Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract. Int J Cancer. 2011;129: 1889-1898.
34. Melotte V, Lentjes MH, van den Bosch SM, et al. N- Myc downstreemregulated gene4 (NDRG4) a candidate tumor suppressor gene and a potential biomarker for colorectal cancer. J Natl Cancer Inst. 2009; 101:916-927.
35. Bosch LJ, Oort FA, Neerincx M, et al. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT. Cancer Prev Res. 2012;5:464-472.
36. Schuebel KE, Chen W, Cope L, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 2007; Available at: e157.doi:10.1371/journal.pgen.0030157
37. The role of colonoscopy in the management of patients with inflammatory bowel disease. American Society for Gastrointestinal Endoscopy. Gastrointestinal Endosc. 1998;48:689-690.